Stemtech (STEK) Non Operating Income (2021 - 2025)
Stemtech's (STEK) quarterly Non Operating Income came in at $833794.0 in Q4 2025, down 18.69% year-on-year from $1.0 million in Q4 2024, and up 2257.01% quarter-over-quarter from $35375.0 in Q3 2025.
Stemtech (STEK) Non Operating Income (2021 - 2025) Analysis & Trends
Stemtech has disclosed Non Operating Income across 5 years of filings, most recently posting $833794.0 for Q4 2025.
- Non Operating Income for Q4 2025 came in at $833794.0, down 18.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $620056.0 (up 24.06% YoY), and the FY2025 annual result was $111357.0, up 61.71% from the prior year.
- Non Operating Income came in at $833794.0 for Q4 2025 at Stemtech, up from $35375.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.0 million in Q4 2024 to a low of -$23.9 million in Q2 2022.
- The 5-year median for Non Operating Income is -$77212.5 (2021), against an average of -$1.6 million.
- Peak annual rise in Non Operating Income reached 5265.75% in 2024, while the deepest fall reached 62534.01% in 2024.
- Stemtech's Non Operating Income stood at -$3.9 million in 2021, then climbed by 8.82% to -$3.5 million in 2022, then jumped by 100.54% to $19110.0 in 2023, then surged by 5265.75% to $1.0 million in 2024, then retreated by 18.69% to $833794.0 in 2025.
- The last three Non Operating Income figures came in at $833794.0 (Q4 2025), $35375.0 (Q3 2025), and $4708.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Stemtech | - | - | 354,677.00 | 833,794.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 833,794.00 |
| Sep 30, 2025 | 35,375.00 |
| Jun 30, 2025 | 4,708.00 |
| Mar 31, 2025 | -253,821.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | -454,935.00 |
| Jun 30, 2024 | -91,778.00 |
| Mar 31, 2024 | 21,141.00 |
| Dec 31, 2023 | 19,110.00 |
| Sep 30, 2023 | -427,573.00 |
| Jun 30, 2023 | 147.00 |
| Mar 31, 2023 | -1.02 Mn |
| Dec 31, 2022 | -3.52 Mn |
| Sep 30, 2022 | 9,284.00 |
| Jun 30, 2022 | -23.94 Mn |
| Mar 31, 2022 | -328,880.00 |
| Dec 31, 2021 | -3.86 Mn |
| Sep 30, 2021 | 28,479.00 |
| Jun 30, 2021 | -62,647.00 |
| Mar 31, 2021 | -95,370.00 |